Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLARA: Omega-3 PUFAs in Breast Tumors
NCT07643428Phase 2Not yet recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Nov 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in breast cancer, sponsored by Medical College of Wisconsin. Primary endpoint: Lipid species in primary breast tumors at 32 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07643428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07643428.